C. E. Hollak

913 total citations · 1 hit paper
7 papers, 718 citations indexed

About

C. E. Hollak is a scholar working on Physiology, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, C. E. Hollak has authored 7 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Molecular Biology and 2 papers in Economics and Econometrics. Recurrent topics in C. E. Hollak's work include Lysosomal Storage Disorders Research (4 papers), Studies on Chitinases and Chitosanases (3 papers) and Pharmaceutical Economics and Policy (2 papers). C. E. Hollak is often cited by papers focused on Lysosomal Storage Disorders Research (4 papers), Studies on Chitinases and Chitosanases (3 papers) and Pharmaceutical Economics and Policy (2 papers). C. E. Hollak collaborates with scholars based in Netherlands, United Kingdom and Israel. C. E. Hollak's co-authors include Johannes M. F. G. Aerts, Sonja van Weely, Martin Hřebı́ček, Raymond A. Dwek, Robin Lachmann, Terry D. Butters, Timothy M. Cox, Chris Moyses, Ari Zimran and Frances M. Platt and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Acta Paediatrica.

In The Last Decade

C. E. Hollak

7 papers receiving 700 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis

2000 592 citations Timothy M. Cox, Robin Lachmann et al. The Lancet profile →

Peers

C. E. Hollak

PHYSI

OC

MB

CB

EPIDE

Karen Ghauharali Netherlands

Raul Chertkoff Israel

Einat Brill‐Almon Israel

Helen Elliott Australia

P. Durand Italy

Carol S. Miller United States

Henrik Gold Netherlands

D. M. Broadhead United Kingdom

J. U. Ikonne United States

C.D. Warren United States

Karen Ghauharali Netherlands

C. E. Hollak

360 ×0.6

PHYSI

180 ×0.5

OC

264 ×0.9

MB

177 ×0.7

CB

119 ×0.5

EPIDE

Citations per year, relative to C. E. Hollak C. E. Hollak (= 1×) peers Karen Ghauharali

Countries citing papers authored by C. E. Hollak

Since Specialization

Citations

This map shows the geographic impact of C. E. Hollak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. E. Hollak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. E. Hollak more than expected).

Fields of papers citing papers by C. E. Hollak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. E. Hollak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. E. Hollak. The network helps show where C. E. Hollak may publish in the future.

Co-authorship network of co-authors of C. E. Hollak

This figure shows the co-authorship network connecting the top 25 collaborators of C. E. Hollak. A scholar is included among the top collaborators of C. E. Hollak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. E. Hollak. C. E. Hollak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Schutte, Tim, et al.. (2023). Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries. ESMO Open. 8(2). 101208–101208. 13 indexed citations

2.

Laarhoven, Hanneke W.M. van, et al.. (2022). Time to access to novel anticancer drugs in Europe, a case study in seven European countries.. Journal of Clinical Oncology. 40(16_suppl). 1586–1586. 2 indexed citations

3.

Aerts, Johannes M. F. G., et al.. (2005). Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases. Acta Paediatrica. 94(s447). 43–46. 61 indexed citations

4.

Aerts, Johannes M. F. G., et al.. (2005). Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases. Acta Paediatrica. 94(0). 43–46. 45 indexed citations

5.

Cox, Timothy M., Robin Lachmann, C. E. Hollak, et al.. (2000). Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. The Lancet. 355(9214). 1481–1485. 592 indexed citations breakdown →

6.

Hollak, C. E., et al.. (1996). [The treatment of Gaucher's disease in The Netherlands using enzyme substitution therapy].. PubMed. 140(19). 1011–3. 1 indexed citations

7.

Hollak, C. E., et al.. (1990). Thrombocytopenic purpura as first manifestation of human immunodeficiency virus type I (HIV-1) infection.. PubMed. 37(1-2). 63–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact